Inclusion Criteria:~* Male or female patient aged â‰¥ 50 years;~* Probable Alzheimer's disease diagnosed by the
National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and
Related Disorders Association (NINCDS-ADRDA) criteria;~* MMSE score between 10-26, inclusive;~* Patient has
been treated with donepezil 10 mg per day for at least 3 months prior to screening;~* Patient able to
participate in all study evaluations and ingest oral medication as indicated;~* Patient has a responsible
caregiver who will accompany the patient to all clinic visits during the study;~* Patient and the responsible
caregiver have provided written informed consent before undergoing any study procedures.~
